Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer

Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma (PDAC) is an expeditiously fatal malignancy with a five-year survival rate of 6–8%. Conventional chemotherapeutics fail in many cases due to inadequate primary response and rapidly developing resistance. This treatment failure is particularly challenging in pancreati...

Full description

Bibliographic Details
Main Authors: Muhammad R. Haque, Trevor H. Rempert, Taslim A. Al-Hilal, Chengyao Wang, Abhinav Bhushan, Faraz Bishehsari
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
pancreatic ductal adenocarcinoma
microfluidics
organ-on-a-chip
tumor microenvironment
tissue engineering
Online Access:https://www.mdpi.com/2072-6694/13/17/4487

Internet

https://www.mdpi.com/2072-6694/13/17/4487

Similar Items